Eisai Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Combined Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Single Dose Study to Assess Food Effect of E2086 in Healthy Adult Subjects

E2086-A001-002

Study Overview

E2086
N/A
NCT06481488
Jun 2024 - Dec 2024
Healthy Volunteers
1. Part A: Number of Participants With Treatment-emergent Adverse Events (TEAEs) [Time Frame: Day 10]

2. Part A: Number of Participants With Serious Adverse Events (SAEs) [Time Frame: Day 10]

3. Part A: Number of Participants With Clinically Significant Abnormal Laboratory Parameters [Time Frame: Day 10]

4. Part A: Number of Participants With Clinically Significant Abnormal Vital Signs Values [Time Frame: Day 10]

  • Males and females 18 Years to 55 Years (Adult)

  • Completed

  • Phase 1

  • United States

Clinical Trial Documents

Clinical Study Report Synopsis

No download available

Plain Language Protocol Synopsis (PLPS)

Download PDF

Plain Language Summary of Results (PLS)

No download available

Publication reference citation

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is not available for this study.

CSDR Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type Availability
Protocol
SAP
Sample CRF
Full CSR